Handelsbanken Fonder AB Has $26.74 Million Stake in Merit Medical Systems, Inc. $MMSI

Handelsbanken Fonder AB grew its position in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 42.0% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 321,309 shares of the medical instruments supplier’s stock after purchasing an additional 95,000 shares during the quarter. Handelsbanken Fonder AB owned approximately 0.54% of Merit Medical Systems worth $26,743,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Assenagon Asset Management S.A. acquired a new position in shares of Merit Medical Systems in the 3rd quarter valued at about $1,644,000. Norges Bank bought a new stake in Merit Medical Systems in the second quarter worth approximately $53,697,000. Fort Washington Investment Advisors Inc. OH increased its holdings in Merit Medical Systems by 69.7% in the third quarter. Fort Washington Investment Advisors Inc. OH now owns 301,718 shares of the medical instruments supplier’s stock worth $25,112,000 after purchasing an additional 123,912 shares in the last quarter. Envestnet Asset Management Inc. lifted its stake in Merit Medical Systems by 5.3% in the second quarter. Envestnet Asset Management Inc. now owns 244,163 shares of the medical instruments supplier’s stock valued at $22,824,000 after buying an additional 12,256 shares during the period. Finally, Westwood Holdings Group Inc. boosted its holdings in shares of Merit Medical Systems by 11.9% during the 2nd quarter. Westwood Holdings Group Inc. now owns 768,970 shares of the medical instruments supplier’s stock worth $71,883,000 after buying an additional 81,469 shares in the last quarter. Institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Stock Performance

Shares of Merit Medical Systems stock opened at $77.18 on Friday. Merit Medical Systems, Inc. has a 52 week low of $76.68 and a 52 week high of $107.27. The company has a quick ratio of 2.86, a current ratio of 4.34 and a debt-to-equity ratio of 0.46. The business has a 50 day moving average price of $83.52 and a 200-day moving average price of $84.85. The company has a market cap of $4.59 billion, a PE ratio of 36.41, a price-to-earnings-growth ratio of 2.26 and a beta of 0.61.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.08. The business had revenue of $393.94 million during the quarter, compared to the consensus estimate of $390.77 million. Merit Medical Systems had a return on equity of 13.82% and a net margin of 8.48%.Merit Medical Systems’s revenue was up 10.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.93 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Equities analysts anticipate that Merit Medical Systems, Inc. will post 3.37 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

MMSI has been the topic of a number of research reports. Needham & Company LLC dropped their target price on shares of Merit Medical Systems from $108.00 to $101.00 and set a “buy” rating on the stock in a research report on Wednesday. BTIG Research assumed coverage on shares of Merit Medical Systems in a research note on Friday, February 6th. They issued a “buy” rating and a $107.00 price target for the company. Piper Sandler cut their price objective on shares of Merit Medical Systems from $113.00 to $106.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 18th. Robert W. Baird set a $108.00 target price on Merit Medical Systems in a research report on Tuesday, December 16th. Finally, Canaccord Genuity Group upped their price target on Merit Medical Systems from $93.00 to $99.00 and gave the stock a “buy” rating in a research note on Wednesday, December 17th. Eight research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $103.33.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.